About this trial
Diverticular disease is one of the most common diseases of the gastrointestinal tract in industrial countries. Prevalence and admission rate due to diverticular disease increases.
Symptomatic patients usually present with acute uncomplicated or complicated diverticulitis. Recurrence rates of complicated diverticulitis are estimated to 10-30%. Recurrences, chronic complications or persisting pain, here collectively referred to as chronic diverticular disease, may be treated by elective sigmoidectomy. Currently, there is no specific criteria for elective surgery, but only a recommendation of a tailored approach depending on the patient's symptoms.
It is well established that diverticular disease has a negative impact on quality of life (QoL). Elective laparoscopic sigmoidectomy may increase QoL.
In this prospective study, we will prospectively examine QoL, patient-related outcomes and peri- and postoperative outcome of elective sigmoidectomy for chronic diverticular disease, and compare it to conservatively treated patients.
Eligibility criteria
Qualifiers
Referred to surgical clinic due to diverticular disease
Colonic diverticula verified by CT or endoscopy
Disqualifiers
Previous colonic resection other than appendectomy
Previous or current colorectal cancer
Previous or current disseminated cancer
Inflammatory bowel disease
Trial design
Treatments tested in this trial
- Sigmoidectomy
- Conservative
Treatment groups
Sponsors and collaborators
University of Aarhus
Lead sponsor
Randers Regional Hospital
Collaborator